Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-13

Clinical Trial Update: Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation [EARLY_Phase 1]

View source ↗

Summary

Early phase 1 trial exploring effects of aminocaproic acid on rosacea inflammation. Completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMINOCAPROIC ACID (aminocaproic acid)

Snippet

Sponsor: University of California, San Diego | Conditions: Rosacea | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-09-13